Syndecan-2

Syndecan-2 is a protein that in humans is encoded by the SDC2 gene. As a member of the syndecan family, Syndecan-2 is an integral membrane protein involved in cell proliferation, cell migration, and cell-matrix interactions. This protein plays a significant role in the regulation of cellular processes by interacting with the extracellular matrix (ECM) and cytoplasmic proteins. Syndecan-2 is predominantly expressed in fibroblasts, endothelial cells, and neurons, indicating its diverse functions in different tissue types.

Structure

Syndecan-2 is characterized by its core protein to which several heparan sulfate glycosaminoglycan chains are attached. The core protein consists of a large extracellular domain, a single transmembrane domain, and a short cytoplasmic tail. The extracellular domain interacts with components of the ECM, such as fibronectin, collagen, and growth factors, facilitating cell-ECM communication. The cytoplasmic domain interacts with cytoskeletal and signaling proteins, mediating intracellular signaling pathways.

Function

The primary function of Syndecan-2 is to mediate cell adhesion and communication with the extracellular matrix. Through its interactions with ECM proteins, Syndecan-2 participates in the regulation of cell morphology, proliferation, and migration. It is also involved in the modulation of several signaling pathways, including those related to wound healing, inflammation, and tumor growth.

In the nervous system, Syndecan-2 plays a crucial role in neuronal development and synapse formation. It has been shown to regulate dendritic spine morphology and is involved in the formation of excitatory synapses, affecting neuronal plasticity and function.

Clinical Significance

Alterations in the expression or function of Syndecan-2 have been associated with various pathological conditions. Overexpression of Syndecan-2 has been observed in several types of cancer, including breast cancer and colorectal cancer, where it is thought to contribute to tumor progression and metastasis. In contrast, reduced expression of Syndecan-2 has been linked to impaired wound healing and fibrosis.

Given its role in cancer and wound healing, Syndecan-2 is considered a potential target for therapeutic intervention. Strategies to modulate its expression or function are being explored for the treatment of cancer and other diseases characterized by abnormal cell proliferation and migration.

Research Directions

Current research on Syndecan-2 focuses on elucidating its precise mechanisms of action in various cellular processes and pathological conditions. Studies aim to understand how Syndecan-2 interacts with other cell surface receptors, ECM components, and intracellular signaling molecules. Additionally, there is interest in developing therapeutic agents that can specifically target Syndecan-2 to modulate its activity in diseases such as cancer and fibrosis.

See Also

• Syndecan
• Extracellular matrix
• Cell adhesion
• Glycosaminoglycan

References

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian